Iambic Therapeutics prices 9.38M share IPO at $16.00/share
bymuratdeniz
Iambic Therapeutics (IAM) announced the pricing of its initial public offering of 9.38M shares of common stock at $16.00 per share. The offering is expected to generate gross proceeds of $150M.
All shares in the offering are being sold directly by Iambic.
The shares are scheduled to begin trading today, October 15, 2026, on the Nasdaq Global Select Market under the ticker symbol "IAM."
Iambic has granted the underwriters a 30-day option to purchase up to an additional 1.41M shares of common stock at the initial public offering price, less underwriting discounts and commissions.
The company will use the proceeds from the IPO to advance three early-stage cancer drug candidates.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.